Science Explorer Back to mapMap
Discussion
Researcher · Centre Léon Bérard · France

Olivia Le Saux

Olivia Le Saux publishes mostly in Oncology, Reproductive Medicine and Pulmonary and Respiratory Medicine, on topics such as Ovarian cancer diagnosis and treatment, Endometrial and Cervical Cancer Treatments and Cancer Immunotherapy and Biomarkers.

ORCID 0000-0002-7815-323X OpenAlex
World rank
#1,526,037
of 7,710,434 ranked researchers
Rank in France
#68,339
of 324,115
Works
159
Citations
1.3k
Citations per work
8.0
h-index
19
i10-index 36Top 25% in Oncology
Olivia Le Saux

What does Olivia Le Saux research?

Olivia Le Saux's work is mostly in Medicine (46%), Immunology and Microbiology (6%), Biochemistry, Genetics and Molecular Biology (6%).

Health Sciences: 73 works · 46.2% of their workMedicine: 73 works · 46.2% of their workOncology: 31 works · 19.5% of their workReproductive Medicine: 20 works · 12.8% of their workPulmonary and Respiratory Medicine: 11 works · 7.2% of their workObstetrics and Gynecology: 11 works · 6.7% of their workEverything else: 67 works · 41.9% of their workLife Sciences: 19 works · 11.9% of their workImmunology and Microbiology: 10 works · 6.1% of their workImmunology: 10 works · 6.1% of their workBiochemistry, Genetics and Molecular Biology: 9 works · 5.8% of their workGenetics: 9 works · 5.8% of their workTHEIR WORKOlivia Le Saux159works
Life Sciences12%Health Sciences46%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine7346.2%
  2. Everything else6741.9%
    1. Immunology and Microbiology106.1%
    2. Biochemistry, Genetics and Molecular Biology95.8%
  1. 1Oncology20% of their works
  2. 2Reproductive Medicine13% of their works
  3. 3Pulmonary and Respiratory Medicine7% of their works
  4. 4Obstetrics and Gynecology7% of their works
  5. 5Immunology6% of their works
  6. 6Genetics6% of their works

Research topics

Which keywords describe Olivia Le Saux's research?

The keywords of their largest research topics: Genomic Analysis, Ovarian Cancer, Cervical Cancer, Endometrial Carcinoma, Immune Checkpoint Blockade, PD-1 and PD-L1, BRCA Mutation and PARP Inhibitors.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 16 words, with their numbers
  1. Genomic Analysis451 topic
  2. Ovarian Cancer451 topic
  3. Cervical Cancer201 topic
  4. Endometrial Carcinoma201 topic
  5. Immune Checkpoint Blockade201 topic
  6. PD-1 and PD-L1201 topic
  7. BRCA Mutation141 topic
  8. PARP Inhibitors141 topic
  9. Frailty111 topic
  10. Geriatric Assessment111 topic
  11. Arterial Calcification101 topic
  12. Pseudoxanthoma Elasticum101 topic
  13. Cancer Genomics91 topic
  14. Mutational Signatures91 topic
  15. Dendritic Cells81 topic
  16. Immunity81 topic

Where does Olivia Le Saux work?

Olivia Le Saux's main affiliation in the publication record is Centre Léon Bérard, France.

How many publications and citations does Olivia Le Saux have?

OpenAlex counts 159 works and 1,268 citations for Olivia Le Saux, an h-index of 19, ranking #1,526,037 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Olivia Le Saux. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.